Therapeutic potential of drugs with mixed 5-HT4 agonist/5-HT3 antagonist action in the control of emesis
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference30 articles.
1. 5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders;Costall;Scand J Gastroenterol,1990
2. The psychopharmacology of 5HT3 receptors;Costall;Pharmacol Toxicol,1992
3. Prokinetic and antiemetic properties of BIMU 1, a 5-HT4 receptor agonist and 5HT3 receptor antagonist;Rizzi,1992
4. Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action;Tonini;Pharmacol Res,1991
5. Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors;Rizzi;Naunyn-Schmiedebergs Arch Pharmacol,1994
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective;Pharmacological Reports;2023-08-16
2. Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice;Biology;2021-12-20
3. Non‐Achalasia Esophageal Motility Abnormalities;The Esophagus;2021-04-30
4. The effect of prucalopride on gastric sensorimotor function and satiation in healthy volunteers;Neurogastroenterology & Motility;2021-02-02
5. Effect of clarithromycin pre-treatment on the pharmacokinetics of metoclopramide after their simultaneous oral intake;Expert Opinion on Drug Metabolism & Toxicology;2020-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3